Search Results 101-110 of 28532 for crohns disease

  1. Pilot Study on FDG PET/MRE for Stricture Assessment in Crohn’s Disease - Mayo Clinic

    ... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  2. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) ... and stage of disease, and previous treatments or health concerns ...

  3. Digestive Diseases News - Medical Professionals - Mayo Clinic

    Five individuals with inflammatory bowel disease (IBD) and obesity experienced effective weight loss after endoscopic bariatric therapy (EBT). April 21, 2023 ...

  4. A Study to Develop the Use of Ultrasound to Monitor Treatment of Crohn's Disease - Mayo Clinic

    The purpose of this study is to compare the effectiveness of ultrasound with magnetic resonance (MR) enterography in the diagnosing and monitoring of Crohn's ...

  5. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

    ... Crohn's disease who were previously enrolled in the etrolizumab Phase III Study GA29144. ... Participant eligibility includes age, gender, type and stage of ...

  6. Improving the Quality of Care for Adults with Inflammatory Bowel Disease - Mayo Clinic

    The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients and ...

  7. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

    Patients of either gender ≥ 18 years and ≤ 75 years of age. Patients with Crohn's Disease (CD) diagnosed at least 6 months prior to Screening visit in ...

  8. A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease - Mayo Clinic

    Clinical Trials · A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease · More about research at Mayo Clinic · Mayo Clinic Footer.

  9. A Study to Evaluate the Effectiveness and Safety of TD-1473 in Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness, safety and tolerability of TD-1473 in subjects with moderately-to-severely active Crohn's Disease ...

  10. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

    ... Crohn's Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population ... Participant eligibility includes age, gender, type and stage of disease, and ...